ABOUT THE EVENT
Date: Tuesday, September 1, 2026 8am–6:10pm PDT
Event Location: San Francisco, California
Consider a day spent alongside the experts shaping the future of antibody therapeutics, scientists, innovators, and decision-makers from across pharma and biotech, all focused on advancing next-generation biologics. That is what the Antibody Therapeutics Xchange San Francisco 2026 offers. This invitation-only, highly curated meeting provides direct access to senior expertise and the opportunity to build meaningful relationships that can influence discovery strategies and pipeline success.
Across dedicated tracks including Target Selection and Mechanisms of Action, Lead Identification and Optimization, Formats and Scaffolds, Bi and Multispecifics, and ADC Linker Design and Cytotoxic Payloads, attendees will explore the key scientific and translational challenges driving innovation in antibody therapeutics. Discussions will address areas such as multispecific design, AI-driven discovery, engineering complexity, payload optimisation, and overcoming resistance mechanisms, all grounded in real-world experience and current industry priorities.
The agenda is designed to maximise interaction and value, combining keynote and spotlight presentations, poster sessions, expert-led roundtables, and pre-scheduled one-to-one meetings. Structured networking throughout the day, including dedicated breaks, lunch, and a closing drinks reception, ensures ample opportunity to exchange insights, benchmark approaches, and identify high-value collaborations.
Taking place in San Francisco on Wednesday 2nd September 2026 at the DoubleTree by Hilton San Francisco Airport Hotel, this Xchange connects a focused community of senior leaders working at the forefront of antibody therapeutics. Registration is complimentary for qualified attendees.
